SEC Form 4Coverage since May 22, 2026
$TXG insider trading
Over the last 12 months, 10x Genomics insiders reported no purchases and 5 sales totaling $2.3M across SEC Form 4 filings. 60% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $2.3M 5 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 4 distinct reporters
- 10b5-1 share
- 60% pre-arranged plans
Side
Price · $TXG · 12Mvia TradingView
Top insiders · 12m
Saxonov SergeChief Executive Officer2× · $1.5M
SULIMAN SHEHNAAZ—1× · $187K
Hindson Benjamin J.See Remarks1× · $283K
Taich AdamChief Financial Officer1× · $369K
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Saxonov SergeChief Executive Officer · O·D | ▼ Sale | 30,000 | $34.44 | $1.0M | -2.6% | plan · 4 tranches |
| Jun 16, 2026 | SULIMAN SHEHNAAZD | ▼ Sale | 5,723 | $32.63 | $187K | -15.3% | plan · 2 tranches |
| May 22, 2026 | Saxonov SergeChief Executive Officer · O·D | ▼ Sale | 18,175 | $24.44 | $444K | -1.6% | plan |
| May 22, 2026 | Hindson Benjamin J.See Remarks · O·D | ▼ Sale | 11,595 | $24.44 | $283K | -2.3% | — |
| May 22, 2026 | Taich AdamChief Financial Officer · O | ▼ Sale | 15,098 | $24.44 | $369K | -3.8% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $TXG feed.